JAK/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis
JAK/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis
复制标题
JAK/STAT信号控制狼疮肾炎中CD8()CD103()组织驻留记忆T细胞的命运
DOI:
10.1016/j.jaut.2020.102424
复制
发表时间:
2020-05-01
影响因子:
12.8
通讯作者:
Yang, Niansheng
中科院分区:
文献类型:
--
作者:
Zhou, Mianjing;Guo, Chaohuan;Yang, Niansheng
Autoimmune mediated inflammation and renal damage in lupus nephritis (LN) depends partly on the infiltration of lymphocytes in glomeruli and renal interstitium. Here we identified a population of CD8(+) T cells with a CD103(+)-phenotype in the healthy kidneys of human and mouse. These cells were typically CD69(+)CD103(+) tissue-resident memory T cells (T-RM) in the kidney. CD8(+) T-RM cells were expanded in the kidneys of patients with LN or MRL/lpr mice. The expansion of renal CD8(+) T-RM cells correlated significantly with kidney disease activity. These cells were active in producing cytokines, perforin and granzyme B in the kidney of MRL/lpr mice. Importantly, renal CD8+ T-RM cells underwent proliferation and self-renewal to maintain a stable T-RM pool in the kidney of MRL/lpr mice, contributing to renal inflammation and damage. JAK/STAT signaling in the MRL/lpr mice was required for renal T-RM self-renewal as well as maintenance of effector functions. Targeting JAK/STAT signaling by tofacitinib effectively suppressed effector functions and impaired the survival of renal T-RM cells in the kidney, contributing to improved kidney function in MRL/lpr mice. These results provided evidences that renal CD8(+) T-RM cells play a role in the pathogenesis of LN. They could serve as a therapeutic target for LN.